Lataa...
Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy
OBJECTIVES: Obesity and diabetes are strong risk factors that drive the development of type I endometrial cancers. Recent epidemiological evidence suggests that metformin may lower cancer risk and reduce rates of cancer deaths among diabetic patients. In order to better understand metformin's a...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2789879/ https://ncbi.nlm.nih.gov/pubmed/19822355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.09.024 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|